A detailed history of Waddell & Associates, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Waddell & Associates, LLC holds 24,978 shares of PFE stock, worth $664,914. This represents 0.09% of its overall portfolio holdings.

Number of Shares
24,978
Previous 24,590 1.58%
Holding current value
$664,914
Previous $688,000 4.94%
% of portfolio
0.09%
Previous 0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$27.7 - $31.39 $10,747 - $12,179
388 Added 1.58%
24,978 $722,000
Q2 2024

Aug 06, 2024

BUY
$25.26 - $29.6 $291,677 - $341,791
11,547 Added 88.53%
24,590 $688,000
Q1 2024

May 08, 2024

SELL
$25.89 - $29.73 $198,084 - $227,464
-7,651 Reduced 36.97%
13,043 $361,000
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $359,862 - $467,421
-13,772 Reduced 39.96%
20,694 $595,000
Q3 2023

Nov 07, 2023

BUY
$32.09 - $37.51 $2,727 - $3,188
85 Added 0.25%
34,466 $1.14 Million
Q2 2023

Aug 07, 2023

SELL
$36.12 - $41.79 $92,720 - $107,274
-2,567 Reduced 6.95%
34,381 $1.26 Million
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $77,361 - $100,713
1,964 Added 5.61%
36,948 $1.51 Million
Q4 2022

Feb 09, 2023

BUY
$41.75 - $54.5 $13,735 - $17,930
329 Added 0.95%
34,984 $1.79 Million
Q3 2022

Nov 02, 2022

BUY
$43.76 - $53.42 $1,925 - $2,350
44 Added 0.13%
34,655 $1.52 Million
Q2 2022

Jul 27, 2022

SELL
$46.53 - $55.17 $977 - $1,158
-21 Reduced 0.06%
34,611 $1.82 Million
Q1 2022

Apr 21, 2022

BUY
$45.75 - $56.69 $87,977 - $109,014
1,923 Added 5.88%
34,632 $1.79 Million
Q4 2021

Feb 01, 2022

BUY
$41.32 - $61.25 $149,165 - $221,112
3,610 Added 12.41%
32,709 $1.93 Million
Q3 2021

Nov 10, 2021

SELL
$39.25 - $50.42 $25,591 - $32,873
-652 Reduced 2.19%
29,099 $1.25 Million
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $1.07 Million - $1.21 Million
29,751 New
29,751 $1.17 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Waddell & Associates, LLC Portfolio

Follow Waddell & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waddell & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waddell & Associates, LLC with notifications on news.